Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic Plasma Infusion Therapy for Congenital TTP
NCT01754545Phase 4Withdrawn
- Sponsor
- St. Olavs University Hospital
- Start
- Sep 2012
- Primary completion
- Nov 2012
- Modality
- Recombinant Proteins and Enzymes, Tissue Cells
01
Overview
A Phase 4 trial of fresh-frozen plasma in congenital thrombotic thrombocytopenic purpura (cTTP), sponsored by St. Olavs University Hospital. Planned start Sep 2012; status: withdrawn.
02
Drugs
fresh-frozen plasma
03
Conditions
congenital thrombotic thrombocytopenic purpura (cTTP)
Beyond the preview
Go deeper on NCT01754545.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01754545.